Best Agrolife (539660) investor relations material

Executive summary

• FY26 was challenging due to adverse weather, uneven rainfall, high trade inventory, and raw material price spikes from the Gulf conflict, impacting sales and profitability.

• Focus remained on strengthening fundamentals, operational discipline, and long-term business sustainability, including OPEX reduction by 15% YoY and working capital optimization.

• Strategic emphasis on expanding patented and specialty product portfolios, with three new patented formulations launched and seven new patents granted, including innovations in Nano Urea and combination products.

• International expansion continued with registrations in Mexico, Sri Lanka, Thailand, and Vietnam, and a subsidiary in Brazil in progress.

• Operational initiatives included inventory reduction, OPEX reduction, and improved cash flow.

Financial highlights

• FY26 consolidated revenue from operations was ₹1,257 crore, down 31% year-over-year from ₹1,814 crore.

• Gross margin for FY26 was ₹380 crore (30%), compared to ₹531 crore (29%) in FY25; Q4 FY26 gross margin was ₹35 crore (23%).

• EBITDA for FY26 was ₹100 crore (8% margin), down from ₹200 crore (11%) in FY25; Q4 FY26 EBITDA was negative at ₹-27 crore.

• Profit after tax for FY26 was ₹9 crore (1% margin), compared to ₹70 crore (4%) in FY25; Q4 FY26 PAT loss was ₹37 crore.

• Diluted EPS for FY26 was ₹0.25, down from ₹1.97 in FY25.

Outlook and guidance

• Four new patented products are planned for launch in FY27 to drive future growth.

• Price increases implemented in April and May 2026 are expected to improve profitability going forward.

• Deferred sales of ₹50–70 crore in March are expected to boost Q1 FY27 results.

• Focus on product mix improvement, inventory alignment, and increased contribution from differentiated products to support gradual recovery.